Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury

NCT ID: NCT01143064

Last Updated: 2024-10-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1195 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SyNAPSe trial will study if giving intravenous (i.v.) progesterone within 8 hours of the injury for a total of 120 hours to severe traumatic brain injury patients improves their recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Progesterone

Group Type ACTIVE_COMPARATOR

Progesterone

Intervention Type DRUG

Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs.

Lipid emulsion without progestrone

Group Type PLACEBO_COMPARATOR

Lipid emulsion without progesterone

Intervention Type DRUG

Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Progesterone

Intravenous administration of 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs.

Intervention Type DRUG

Lipid emulsion without progesterone

Intravenous administration equal to 0.71mg/kg/hr for 1hr followed by 0.5mg/kg/hr administered intravenously for an additional 119 hrs.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BHR-100

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female patients between the age of 16 and 70 years, inclusive
2. Weight from 45 to 135 kg, inclusive
3. Sustained a closed head trauma no more than 8 hours before start of study drug infusion
4. TBI diagnosed by history and clinical examination
5. Post-resuscitation Glasgow Coma Scale (GCS) score between 3 to 8, inclusive
6. At least one reactive pupil (pinpoint pupils due to opioid pain treatment are considered reactive)
7. Evidence of TBI confirmed by abnormalities consistent with trauma on CT scan upon admission (diffuse injury II-IV, evacuated and non-evacuated mass lesion, Marshall's CT Classification)
8. Indication for ICP monitoring

Exclusion Criteria

1. Life expectancy of less than 24 hours as determined by the Investigator
2. Prolonged and/or uncorrectable hypoxia (Pa02\< 60 mmHg) or hypotension (systolic blood pressure \< 90 mmHg) at the time of randomization
3. Any spinal cord injury
4. Pregnancy
5. Penetrating head injury
6. Bilaterally fixed dilated pupils at the time of randomization
7. Coma suspected to be primarily due to other causes (e.g. alcohol)
8. Pure epidural hematoma
9. Preexisting clinically significant disease or chronic condition that can be ascertained at the time of admission and could affect functional outcome
10. Severe cardiac or hemodynamic instability prior to randomization
11. Known treatment with another investigational drug therapy or procedure within 30 days of injury
12. A history of allergic reaction to progesterone and related drugs or any of the components of the infusion
13. Any disease, in the opinion of the Investigator, that is unstable or which could jeopardize the safety of the patient and his/her compliance in the study.
14. Patients who, in the opinion of the Investigator, would not be able or willing to comply with the protocol through the final visit (6 months post-injury)
Minimum Eligible Age

16 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PRA Health Sciences

INDUSTRY

Sponsor Role collaborator

Syneos Health

OTHER

Sponsor Role collaborator

BHR Pharma, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neta R. Nelson, MPH

Role: STUDY_DIRECTOR

BHR Pharma, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Alabama Medical Center

Mobile, Alabama, United States

Site Status

LAC+USC Medical Center

Los Angeles, California, United States

Site Status

University of California San Diego Medical Center

San Diego, California, United States

Site Status

Denver Health Medical Center

Denver, Colorado, United States

Site Status

Christiana Care Health System Hospital

Newark, Delaware, United States

Site Status

Delray Medical Center

Delray Beach, Florida, United States

Site Status

Tallahassee Memorial Healthcare

Tallahassee, Florida, United States

Site Status

Tampa General Hospital

Tampa, Florida, United States

Site Status

Saint Alphonsus Regional Medical Center

Boise, Idaho, United States

Site Status

John H. Stroger Jr. Hospital of Cook County

Chicago, Illinois, United States

Site Status

Advocate Lutheran General Hospital

Park Ridge, Illinois, United States

Site Status

Saint John's Hospital

Springfield, Illinois, United States

Site Status

Wishard Health Services

Indianapolis, Indiana, United States

Site Status

Methodist Hospital

Indianapolis, Indiana, United States

Site Status

Mercy Medical Center

Des Moines, Iowa, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

University of Louisville Hospital

Louisville, Kentucky, United States

Site Status

LSU Health - Shreveport

Shreveport, Louisiana, United States

Site Status

Eastern Maine Medical Center

Bangor, Maine, United States

Site Status

Maine Medical Center

Portland, Maine, United States

Site Status

Baystate Medical Center

Springfield, Massachusetts, United States

Site Status

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, United States

Site Status

Bronson Methodist Hospital

Kalamazoo, Michigan, United States

Site Status

St. Mary's of Michigan

Saginaw, Michigan, United States

Site Status

University of Missouri Health Care

Columbia, Missouri, United States

Site Status

Truman Medical Center Hospital Hill

Kansas City, Missouri, United States

Site Status

Lester E. Cox Memorial Hospital

Springfield, Missouri, United States

Site Status

The Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Robert Wood Johnson University Hospital

New Brunswick, New Jersey, United States

Site Status

Albany Medical Center Hospital

Albany, New York, United States

Site Status

Westchester Medical Center

Valhalla, New York, United States

Site Status

Mission Hospital

Asheville, North Carolina, United States

Site Status

Carolinas Medical Center

Charlotte, North Carolina, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Wake Forest University-Baptist Medical Center

Winston-Salem, North Carolina, United States

Site Status

Summa Health System

Akron, Ohio, United States

Site Status

MetroHealth Medical Center

Cleveland, Ohio, United States

Site Status

Miami Valley Hospital

Dayton, Ohio, United States

Site Status

St. Elizabeth Health Center

Youngstown, Ohio, United States

Site Status

OU Medical Center

Oklahoma City, Oklahoma, United States

Site Status

Legacy Emanuel Hospital & Health Center

Portland, Oregon, United States

Site Status

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

University of South Carolina School of Medicine

Columbia, South Carolina, United States

Site Status

Johnson City Medical Center

Johnson City, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Texas Tech University Health Sciences Center

El Paso, Texas, United States

Site Status

University of Virginia Health System

Charlottesville, Virginia, United States

Site Status

Marshall University Joan C. Edwards School of Medicine

Huntington, West Virginia, United States

Site Status

West Virginia University Hospital

Morgantown, West Virginia, United States

Site Status

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, United States

Site Status

Hospital Francisco Lopez Lima

General Roca, Río Negro Province, Argentina

Site Status

Hospital de Emergencias Clemente Alvarez (HECA)

Rosario, Santa Fe Province, Argentina

Site Status

Hospital Nacional "Profesor Alejandro Posadas"

Buenos Aires, , Argentina

Site Status

Hospital Regional De Comodoro Rivadavia (HRCR)

Comodoro Rivadavia, , Argentina

Site Status

Hospital Central de Mendoza

Mendoza, , Argentina

Site Status

Hospital San Martin

Paraná, , Argentina

Site Status

Hospital Dr. José Maria Cullen

Santa Fé, , Argentina

Site Status

Medizinische Universität Graz

Graz, , Austria

Site Status

Medizinische Universität Innsbruck

Innsbruck, , Austria

Site Status

Unfallkrankenhaus Salzburg

Salzburg, , Austria

Site Status

Landesklinikum Wiener Neustadt

Vienna, , Austria

Site Status

ULB Erasme

Brussels, , Belgium

Site Status

Ziekenhuis Oost-Limburg, Location Sint Jan

Genk, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

University Hospital of the Free University Brussels (UZ Brussel)

Jette, , Belgium

Site Status

University Hospital Gasthuisberg

Leuven, , Belgium

Site Status

Chengdu Military General Hospital

Chengdu, , China

Site Status

The First Affiliated Hospital of Fujian Medical University

Fuzhou, , China

Site Status

The 2nd Affiliated Hospital of Zhejiang University

Hangzhou, , China

Site Status

The Second Hospital of Shandong University

Jinan, , China

Site Status

Huashan Hospital of Fudan University

Shanghai, , China

Site Status

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, , China

Site Status

General Hospital of Tianjin Medical University

Tianjin, , China

Site Status

The Affiliated Hospital of Xuzhou Medical College

Xuzhou, , China

Site Status

Fakultní nemocnice Brno Neurochirurgická klinika

Brno, , Czechia

Site Status

Fakultní nemocnice u sv. Anny v Brnĕ, Neurochirurgická klinika

Brno, , Czechia

Site Status

Fakultní Nemocnice Plzeň, Neurochirurgicé Oddĕlení

Pilsen, , Czechia

Site Status

Fakultní nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

Groupe Hospitalier Pellegrin

Bordeaux, , France

Site Status

Hôpital Pierre Wertheimer

Bron, , France

Site Status

Centre Hospitalier Universitaire de Grenoble- Hópital Michallon

La Tronche, , France

Site Status

CHRU de Lille- Hópital Roger Salengro

Lille, , France

Site Status

Centre Hospitalier Universitaire de Limoges

Limoges, , France

Site Status

Centre Hospitalier Universitaire Hôpital Nord

Marseille, , France

Site Status

Hópital Central - CHU de Nancy

Nancy, , France

Site Status

Groupe Hospitalier La Salpêtrière

Paris, , France

Site Status

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Krankenhaus Merheim

Cologne, , Germany

Site Status

Klinikum der J.W. Goethe-Universität

Frankfurt, , Germany

Site Status

Universitätsmedizin Göttingen

Göttingen, , Germany

Site Status

Berufsgenossenschaftliche Kliniken

Halle, , Germany

Site Status

Universitätsklinikum Hamburg-Eppendorf

Hamburg, , Germany

Site Status

Universitätsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Universitätsklinikum Gießen und Marburg gGmbH

Marburg, , Germany

Site Status

Klinikum Nürnberg

Nuremberg, , Germany

Site Status

Niels-Stensen-Kliniken

Osnabrück, , Germany

Site Status

Universitätsklinikum Ulm

Ulm, , Germany

Site Status

Honvédelmi Minisztérium Állami Egészségügyi Központ

Budapest, , Hungary

Site Status

Pécsi Tudományegyetem Általános Orvostudományi Kar

Pécs, , Hungary

Site Status

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ

Szeged, , Hungary

Site Status

Rambam Medical Center

Haifa, , Israel

Site Status

Hadassah Medical Organization

Jerusalem, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Chaim Sheba Medical Center

Tel Litwinsky, , Israel

Site Status

Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena

Milan, , Italy

Site Status

Fondazione San Raffaele del Monte Tabor

Milan, , Italy

Site Status

Azienda Ospedaliera San Gerardo

Monza, , Italy

Site Status

Azienda Ospedaliero Universitaria Maggiore della Caritá

Novara, , Italy

Site Status

Azienda Ospedaliera San Camillo Forlanini

Rome, , Italy

Site Status

Azienda Ospedaliero Universitaria Integrata di Verona

Verona, , Italy

Site Status

Hospital Raja Permaisuri Bainun

Ipoh, , Malaysia

Site Status

Hospital Kuala Lumpur

Kuala Lumpur, , Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Hospital Tengku Ampuan Afzan

Kuantan, , Malaysia

Site Status

Sarawak General Hospital

Kuching, , Malaysia

Site Status

VU Medisch Centrum

Amsterdam, , Netherlands

Site Status

Universitair Medisch Centrum Groningen

Groningen, , Netherlands

Site Status

Spitalul Clinic Judetean de Urgenta Timisoara

Timișoara, , Romania

Site Status

State Budget Educational Institution of Higher Professional Education "Kemerovskaya State Medical Academy of Federal Agency of Healthcare and Social Development"

Kemerovo, , Russia

Site Status

State Professional Institution of High Professional Education "Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky of Ministry of Health and Social Development"

Krasnoyarsk, , Russia

Site Status

State Institution "Burdenko Neurosurgical Institute of RAMS"

Moscow, , Russia

Site Status

State Healthcare Facility "Murmansk Regional Clinical Hospital n.a. Bayandin"

Murmansk, , Russia

Site Status

Saint Petersburg Healthcare Institution "City Mariinsky Hospital"

Saint Petersburg, , Russia

Site Status

State Institution of Health Care "Sverdlovsk Regional Clinical Hospital #1"

Yekaterinburg, , Russia

Site Status

National Neuroscience Institute

Singapore, , Singapore

Site Status

National University Hospital

Singapore, , Singapore

Site Status

Singapore General Hospital

Singapore, , Singapore

Site Status

Hospital Universitario Germans Trias i Pujol

Badalona, Barcelona, Spain

Site Status

Hospital Parc Taulí

Sabadell, Barcelona, Spain

Site Status

Hospital General Universitario de Alicante

Alicante, , Spain

Site Status

Hospital Universitario de Bellvitge

Barcelona, , Spain

Site Status

Hospital Universitario Vall Hebrón

Barcelona, , Spain

Site Status

Hospital Universitario de Girona Dr. Josep Trueta

Girona, , Spain

Site Status

Hospital Universitario de Gran Canaria Dr. Negrín

Las Palmas de Gran Canaria, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Hospital Universitari Son Espases

Palma de Mallorca, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Clínico Universitario De Valencia

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fé de Valencia

Valencia, , Spain

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Chiang Mai University

Chiang Mai, , Thailand

Site Status

Faculty of Medicine, Prince of Songkla University

Hat Yai, , Thailand

Site Status

Khon Kaen Hospital

Khon Kaen, , Thailand

Site Status

Royal Preston Hospital

Fulwood, Preston, United Kingdom

Site Status

Queen Elizabeth Hospital

Birmingham, , United Kingdom

Site Status

University Hospital Coventry

Coventry, , United Kingdom

Site Status

Leeds Teaching Hospitals NHS, Leeds General Infirmary

Leeds, , United Kingdom

Site Status

The Royal London Hospital

London, , United Kingdom

Site Status

The James Cook University Hospital

Middlesbrough, , United Kingdom

Site Status

Southampton University Hospital

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Austria Belgium China Czechia Finland France Germany Hungary Israel Italy Malaysia Netherlands Romania Russia Singapore Spain Taiwan Thailand United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2. doi: 10.1016/j.annemergmed.2006.07.932. Epub 2006 Sep 29.

Reference Type BACKGROUND
PMID: 17011666 (View on PubMed)

Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12(2):R61. doi: 10.1186/cc6887. Epub 2008 Apr 30.

Reference Type BACKGROUND
PMID: 18447940 (View on PubMed)

Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10.

Reference Type DERIVED
PMID: 25493978 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-018283-16

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

BHR-100-301

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.